Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage
Clinical trial NCT03025789 · COMPLETED
Trial details
- NCT number
- NCT03025789
- Sponsor
- Drugs for Neglected Diseases
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-10
- Primary completion
- 2021-02-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.